2020年度このページを印刷する - 2020年度

2025年1月8日掲載

2020年度
英文論文
  1. K. Matsumoto, Y. Nakamura, Y. Inagaki, Y. Taniguchi, A. Tamiya, Y. Matsuda, T. Kasai, S. Atagi. Mediastinal undifferentiated pleomorphic sarcoma with pleural effusion cytopathologically misdiagnosed as epithelial malignant pleural mesothelioma: An autopsy case report. Thoracic Cancer. 2021 Apr;12(7):1137ー1140.(松本錦之介)
 
  1. N. Tanabe, H. Kumamaru, Y. Tamura, H. Taniguchi, N. Emoto, Y. Yamada, O. Nishiyama, I. Tsujino, H. Kuraishi, Y. Nishimura, H. Kimura, Y. Inoue, Y. Morio, Y. Nakatsumi, T. Satoh, M. Hanaoka, K. Kusaka, M. Sumitani, T. Handa, S. Sakao, T. Kimura, Y. Kondoh, K. Nakayama, K. Tanaka, H. Ohira, M. Nishimura, H. Miyata, K. Tatsumi. Multi-Institutional Prospective Cohort Study of Patients With Pulmonary Hypertension Associated With Respiratory Diseases. Circulation Journal. 2021 Apr;85(4):333ー342.(井上義一)
 
  1. T. Koba, Y. Takeda, R. Narumi, T. Shiromizu, Y. Nojima, M. Ito, M. Kuroyama, Y. Futami, T. Takimoto, T. Matsuki, R. Edahiro, S. Nojima, Y. Hayama, K. Fukushima, H. Hirata, S. Koyama, K. Iwahori, I. Nagatomo, M. Suzuki, Y. Shirai, T. Murakami, K. Nakanishi, T. Nakatani, Y. Suga, K. Miyake, T. Shiroyama, H. Kida, T. Sasaki, K. Ueda, K. Mizuguchi, J. Adachi, T. Tomonaga, A. Kumanogoh. Proteomics of serum extracellular vesicles identifies a novel COPD biomarker, fibulin-3 from elastic fibres. ERJ Open Res. 7(1):(滝本宜之)
 
  1. I. Maeda, E. Satomi, D. Kiuchi, K. Nishijima, Y. Matsuda, A. Tokoro, K. Tagami, Y. Matsumoto, A. Naito, T. Morita, S. Iwase, H. Otani, T. Odagiri, H. Watanabe, M. Mori, Y. Matsuda, H. Nagaoka, M. Mayuzumi, Y. Kanai, N. Sakamoto, K. Ariyoshi. Patient-perceived symptomatic benefits of olanzapine treatment for nausea and vomiting in patients with advanced cancer who received palliative care through consultation teams: a multicenter prospective observational study. Supportive Care in Cancer. 2021 Mar;8.(松田能宣)
 
  1. H. Itami, T. Fujii, T. Nakai, M. Takeda, Y. Kishi, F. Taniguchi, C. Terada, F. Okada, Y. Nitta, M. Matsuoka, S. Sasaki, S. Sugimoto, T. Uchiyama, K. Morita, T. Kasai, R. Kawaguchi, C. Ohbayashi. TRAF7 mutations and immunohistochemical study of uterine adenomatoid tumor compared with malignant mesothelioma. Hum Pathol. 11159ー66.(武田麻衣子)
 
  1. M. Hirose, T. Arai, C. Sugimoto, T. Takimoto, R. Sugawara, S. Minomo, S. Shintani, N. Takeuchi, K. Katayama, Y. Inoue, T. Kagawa, T. Kasai, M. Akira, Y. Inoue. B cell-activating factors in autoimmune pulmonary alveolar proteinosis. Orphanet Journal of Rare Diseases. 2021 Mar;16(1):10.(広瀬雅樹)
 
  1. T. Enomoto, A. Tamiya, K. Matsumoto, Y. Adachi, K. Azuma, Y. Inagaki, S. Kouno, Y. Taniguchi, N. Saijo, K. Okishio, S. Atagi. Nivolumab treatment beyond progressive disease in advanced non-small cell lung cancer. Clinical & Translational Oncology. 2021 Mar;23(3):582ー590.(田宮朗裕)
 
  1. S. Minomo, T. Kobayashi, K. Katayama, M. Ryuge, T. Kagawa, K. Tsuyuguchi, H. Matsui, K. Suzuki. Risk factors for hemoptysis in Mycobacterium avium complex lung disease. Respiratory Investigation. 2021 Mar;59(2):218ー222.(蓑毛祥次郎)
 
  1. T. Johkoh, K. S. Lee, M. Nishino, W. D. Travis, J. H. Ryu, H. Y. Lee, C. J. Ryerson, T. Franquet, A. A. Bankier, K. K. Brown, J. M. Goo, H. U. Kauczor, D. A. Lynch, A. G. Nicholson, L. Richeldi, C. M. Schaefer-Prokop, J. Verschakelen, S. Raoof, G. D. Rubin, C. Powell, Y. Inoue, H. Hatabu. Chest CT Diagnosis and Clinical Management of Drug-Related Pneumonitis in Patients Receiving Molecular Targeting Agents and Immune Checkpoint Inhibitors: A Position Paper From the Fleischner Society. Chest. 2021 Mar;159(3):1107ー1125.(井上義一)
 
  1. H. Kitaoka, H. Kobayashi, T. Takimoto, T. Kijima. Proposal of selective wedge instillation of pulmonary surfactant for COVID-19 pneumonia based on computational fluid dynamics simulation. Bmc Pulmonary Medicine. 2021 Feb;21(1):5.(滝本宜之)
 
  1. S. Sakaue, E. Yamaguchi, Y. Inoue, M. Takahashi, J. Hirata, K. Suzuki, S. Ito, T. Arai, M. Hirose, Y. Tanino, T. Nikaido, T. Ichiwata, S. Ohkouchi, T. Hirano, T. Takada, S. Miyawaki, S. Dofuku, Y. Maeda, T. Nii, T. Kishikawa, K. Ogawa, T. Masuda, K. Yamamoto, K. Sonehara, R. Tazawa, K. Morimoto, M. Takaki, S. Konno, M. Suzuki, K. Tomii, A. Nakagawa, T. Handa, K. Tanizawa, H. Ishii, M. Ishida, T. Kato, N. Takeda, K. Yokomura, T. Matsui, M. Watanabe, H. Inoue, K. Imaizumi, Y. Goto, H. Kida, T. Fujisawa, T. Suda, T. Yamada, Y. Satake, H. Ibata, N. Hizawa, H. Mochizuki, A. Kumanogoh, F. Matsuda, K. Nakata, T. Hirota, M. Tamari, Y. Okada. Genetic determinants of risk in autoimmune pulmonary alveolar proteinosis. Nature Communications. 2021 Feb;12(1):6.(井上義一)
 
  1. H. Tsujimoto, Y. Kataoka, Y. Sato, M. Banno, E. Tsujino-Tsujimoto, Y. Sumi, R. Sada, T. Fujiwara, Y. Ohtake, J. Kumasawa, H. Imura, Y. Matsuda, R. So, T. Kagawa, T. Yoshioka, Y. Uneno, H. Nagano, M. Akazawa, T. Hozumi, Y. Tsujimoto. A model six-month workshop for developing systematic review protocols at teaching hospitals: action research and scholarly productivity. BMC Med Educ. 21(1):98.(松田能宣)
 
  1. Y. Kurahara. Massive Bronchorrhea. Intern Med. (倉原優)
 
  1. Y. Kurahara. The Detachment Process of Aspergilloma Formation. Intern Med. (倉原優)
 
  1. T. Enomoto, T. Takimoto, T. Kagawa, K. Tachibana, C. Sugimoto, T. Arai, T. Sakurai, T. Kasai, M. Akira, S. Hayashi, Y. Inoue. Histologically Proven Dendriform Pulmonary Ossification: A Five-case Series. Intern Med. (榎本貴俊)
 
  1. A. Takizawa, M. Kamita, Y. Kondoh, M. Bando, M. Kuwana, Y. Inoue. Current monitoring and treatment of progressive fibrosing interstitial lung disease: a survey of physicians in Japan, the United States, and the European Union. Current Medical Research and Opinion. 2021 Feb;37(2):327ー339.(井上義一)
 
  1. N. Ose, Y. Takeuchi, N. Kitahara, A. Matumura, K. Kodama, H. Shiono, Y. Susaki, Y. Funakoshi, H. Takabatake, Y. Shintani, U. Thoracic Surg Study Grp Osaka. Analysis of pulmonary nodules caused by nontuberculous mycobacteriosis in 101 resected cases: multi-center retrospective study. Journal of Thoracic Disease. 2021 Feb;13(2):977ー985.(松村晃秀)
 
  1. T. Johkoh, K. S. Lee, M. Nishino, W. D. Travis, J. H. Ryu, H. Y. Lee, C. J. Ryerson, T. Franquet, A. A. Bankier, K. K. Brown, J. M. Goo, H. U. Kauczor, D. A. Lynch, A. G. Nicholson, L. Richeldi, C. M. Schaefer-Prokop, J. Verschakelen, S. Raoof, G. D. Rubin, C. Powell, Y. Inoue, H. Hatabu. Chest CT Diagnosis and Clinical Management of Drug-related Pneumonitis in Patients Receiving Molecular Targeting Agents and Immune Checkpoint Inhibitors: A Position Paper from the Fleischner Society. Radiology. 298(3):550ー566.(井上義一)
 
  1. T. Takimoto, H. Kitaoka, T. Kijima. What Is Tracheobronchomalacia in Obstructive Lung Disease?. Chest. 159(1):442ー443.(滝本宜之)
 
  1. Yoshinobu Matsuda, Tatsuya Morita, Hirotaka Matsumoto, Keita Hosoi, Kayo Kusama, Yasuo Kohashi, Hiroshi Morishita, Sawako Kaku, Keisukie Ariyoshi, Shunsuke Oyamada, Yoshikazu Inoue, Satoru Iwase, Takuhiro Yamaguchi, and Mitsunori Nishikawa. Predictors of Morphine Efficacy for Dyspnea in Inpatients with Chronic Obstructive Pulmonary Disease: A Secondary Analysis of JORTC-PAL 07. Palliat Med Reports. 2021 Jan;2(1):(松田能宣)
 
  1. T. Harada, H. Imai, S. Fumita, T. Noriyuki, M. Gamoh, M. Okamoto, Y. Akashi, Y. Kizawa, A. Tokoro. Opioid-induced constipation in patients with cancer pain in Japan (OIC-J study): a post hoc subgroup analysis of patients with gastrointestinal cancer. International Journal of Clinical Oncology. 2021 Jan;26(1):104ー110.(所昭宏)
 
  1. H. Saka, M. Nishio, T. Hida, K. Nakagawa, H. Sakai, N. Nogami, S. Atagi, T. Takahashi, H. Horinouchi, M. Takenoyama, N. Katakami, H. Tanaka, K. Takeda, M. Satouchi, H. Isobe, M. Maemondo, K. Goto, T. Hirashima, K. Minato, N. Yada, T. Tamura. Five-year follow-up results from phase II studies of nivolumab in Japanese patients with previously treated advanced non-small cell lung cancer: pooled analysis of the ONO-4538-05 and ONO-4538-06 studies. Japanese Journal of Clinical Oncology. 2021 Jan;51(1):106ー113.(安宅信二)
 
  1. Y. Adachi, T. Takimoto, M. Takeda, K. Matsumoto, N. Takeuchi, T. Kagawa, T. Sakamoto, T. Kasai, C. Sugimoto, Y. Inoue, K. Tachibana, T. Arai, Y. Inoue. Lymphoplasmacytic lymphoma involving the mediastinum and the lung, followed by amyloidosis: A surgically and genetically proven case. Respiratory Medicine Case Reports. 2020;315.(滝本宜之)
 
  1. Taniguchi Y, Tamiya A, Matsuda Y, Adachi Y, Enomoto T, Azuma K, Kouno S, Tokoro A, Atagi S. Opioids impair Nivolumab outcomes: a retrospective propensity score analysis in non-small-cell lung cancer. BMJ Supportive & Palliative Care. 2020 Dec;10(谷口善彦)
 
  1. N. Nishiyama, Y. Matsuda, N. Fujiwara, K. Ariyoshi, S. Oyamada, K. Narita, R. Ishii, S. Iwase. The efficacy of specialised rehabilitation using the Op-reha Guide for cancer patients in palliative care units: protocol of a multicentre, randomised controlled trial (JORTC-RHB02). Bmc Palliative Care. 2020 Oct;19(1):8.(松田能宣)
 
  1. Y. Inagaki, A. Tamiya, Y. Matsuda, K. Azuma, Y. Adachi, T. Enomoto, S. Kouno, Y. Taniguchi, N. Saijo, K. Okishio, S. Atagi. Poor effect of osimertinib on EGFR exon 20 insertion-positive lung adenocarcinoma A case report. Medicine. 2020 Oct;99(42):4.(稲垣雄士)
 
  1. K. Yoh, S. Atagi, M. Reck, E. B. Garon, S. Ponce Aix, D. Moro-Sibilot, K. B. Winfree, B. Frimodt-Moller, A. Zimmermann, C. Visseren-Grul, K. Nakagawa. Patient-reported outcomes in RELAY, a phase 3 trial of ramucirumab plus erlotinib versus placebo plus erlotinib in untreated EGFR-mutated metastatic non-small-cell lung cancer. Current Medical Research and Opinion. 2020 Oct;36(10):1667ー1675.(安宅信二)
 
  1. B. C. Trapnell, Y. Inoue, F. Bonella, C. Morgan, S. Jouneau, E. Bendstrup, I. Campo, S. A. Papiris, E. Yamaguchi, E. Cetinkaya, M. M. Ilkovich, M. R. Kramer, M. Veltkamp, M. Kreuter, T. Baba, C. Ganslandt, I. Tarnow, G. Waterer, T. Jouhikainen. Inhaled Molgramostim Therapy in Autoimmune Pulmonary Alveolar Proteinosis. New England Journal of Medicine. 2020 Oct;383(17):1635ー1644.(井上義一)
 
  1. Mori M, Yamaguchi T, Matsuda Y, Suzuki K, Watanabe H, Matsunuma R, Kako J, Imai K, Usui Y, Matsumoto Y, Hui D, Currow D, Morita T. Unanswered questions and future direction in the management of terminal breathlessness in patients with cancer. ESMO Open. 2020 Sep;(松田能宣)
 
  1. H. Ishiki, J. Hamano, H. Nagaoka, Y. Matsuda, A. Tokoro, H. Matsuoka, H. Izumi, A. Sakashita, Y. Kizawa, S. Oyamada, T. Yamaguchi, S. Iwase. Prevalence of Extrapyramidal Symptoms in Cancer Patients Referred to Palliative Care: A Multicenter Observational Study (JORTC PAL12). American Journal of Hospice & Palliative Medicine. 7.(松田能宣)
 
  1. R. Wang, T. Yamada, K. Kita, H. Taniguchi, S. Arai, K. Fukuda, M. Terashima, A. Ishimura, A. Nishiyama, A. Tanimoto, S. Takeuchi, K. Ohtsubo, K. Yamashita, T. Yamano, A. Yoshimura, K. Takayama, K. Kaira, Y. Taniguchi, S. Atagi, H. Uehara, R. Hanayama, I. Matsumoto, X. Han, K. Matsumoto, W. Wang, T. Suzuki, S. Yano. Transient IGF-1R inhibition combined with osimertinib eradicates AXL-low expressing EGFR mutated lung cancer, Nature Communications. 2020 Sep;11(1):14.(安宅信二)
 
  1. Y. Suzuki, T. Fujisawa, H. Sumikawa, T. Tanaka, C. Sugimoto, M. Kono, H. Hozumi, M. Karayama, K. Furuhashi, N. Enomoto, Y. Nakamura, N. Inui, T. Suda. Disease course and prognosis of pleuroparenchymal fibroelastosis compared with idiopathic pulmonary fibrosis. Respiratory Medicine. 2020 Sep;1717.(杉本親寿)
 
  1. K. Ogawa, Y. Koh, H. Kaneda, M. Izumi, Y. Matsumoto, K. Sawa, M. Fukui, Y. Taniguchi, N. Yoshimoto, A. Tamiya, M. Ando, A. Kubo, S. I. Isa, H. Saka, A. Matsumura, T. Kawaguchi. Can smoking duration alone replace pack-years to predict the risk of smoking-related oncogenic mutations in non-small cell lung cancer? A cross-sectional study in Japan. Bmj Open. 2020;10(9):8.(田宮朗裕)
 
  1. H. Horinouchi, S. Atagi, S. Oizumi, K. Ohashi, T. Kato, T. Kozuki, M. Seike, T. Sone, T. Sobue, T. Tokito, H. Harada, T. Maeda, T. Mio, I. Shirosaka, K. Hattori, E. Shin, H. Murakami. Real-world outcomes of chemoradiotherapy for unresectable Stage III non-small cell lung cancer: The SOLUTION study. Cancer Medicine. 2020 Sep;9(18):6597-6608.(安宅信二)
 
  1. K. Katayama, M. Hirose, T. Arai, K. Hatsuda, K. Tachibana, R. Sugawara, C. Sugimoto, T. Kasai, M. Akira, Y. Inoue. Clinical significance of serum anti-granulocyte-macrophage colony-stimulating factor autoantibodies in patients with sarcoidosis and hypersensitivity pneumonitis. Orphanet Journal of Rare Diseases. 2020 Sep;15(1):10.(片山加奈子)
 
  1. T. Takimoto, T. Kagawa, K. Tachibana, T. Arai, Y. Inoue. Massive atelectasis by mucoid impaction in an asthma patient during treatment with anti-interleukin-5 receptor antibody. Respirology Case Reports. 2020 Aug;8(6):3.(滝本宜之)
 
  1. A. Tamiya, M. Tamiya, H. Go, T. Inoue, K. Kunimasa, K. Nakahama, Y. Taniguchi, T. Shiroyama, S. I. Isa, K. Nishino, T. Kumagai, H. Suzuki, T. Hirashima, S. Atagi, A. Shintani, F. Imamura. A Multivariable Regression Model-based Nomogram for Estimating the Overall Survival of Patients Previously Treated With Nivolumab for Advanced Non-small-cell Lung Cancer. Anticancer Research. 2020 Aug;40(8):4229ー4236.(田宮朗裕)
 
  1. G. Raghu, M. Remy-Jardin, C. J. Ryerson, J. L. Myers, M. Kreuter, M. Vasakova, E. Bargagli, J. H. Chung, B. F. Collins, E. Bendstrup, H. A. Chami, A. T. Chua, T. J. Corte, J. C. Dalphin, S. K. Danoff, J. Diaz-Mendoza, A. Duggal, R. Egashira, T. Ewing, M. Gulati, Y. Inoue, A. R. Jenkins, K. A. Johannson, T. Johkoh, M. Tamae-Kakazu, M. Kitaichi, S. L. Knight, D. Koschel, D. J. Lederer, Y. Mageto, L. A. Maier, C. Matiz, F. Morell, A. G. Nicholson, S. Patolia, C. A. Pereira, E. A. Renzoni, M. L. Salisbury, M. Selman, S. L. F. Walsh, W. A. Wuyts, K. C. Wilson, S. Amer Thoracic, S. Japanese Resp, T. Assoc Latinoamer. Diagnosis of Hypersensitivity Pneumonitis in Adults An Official ATS/JRS/ALAT Clinical Practice Guideline. American Journal of Respiratory and Critical Care Medicine. 2020 Aug;202(3):E36ーE69.(井上義一)
 
  1. T. Arai, M. Akira, C. Sugimoto, K. Tachibana, Y. Inoue, S. Shintani, T. Okuma, T. Kasai, S. Hayashi, Y. Inoue. Seroradiologic prognostic evaluation of acute exacerbation in patients with idiopathic interstitial pneumonia: a retrospective observational study. Journal of Thoracic Disease. 2020 Aug;12(8):4132ー+.(新井徹)
 
  1. K. Okishio, R. Morita, J. Shimizu, H. Saito, H. Sakai, Y. H. Kim, O. Hataji, M. Yomota, M. Nishio, K. Aoe, O. Kanai, T. Kumagai, K. Kibata, H. Tsukamoto, S. Oizumi, D. Fujimoto, H. Tanaka, K. Mizuno, T. Masuda, T. Kozuki, T. Haku, H. Suzuki, I. Okamoto, H. Hoshiyama, N. Yada, Y. Ohe. Nivolumab treatment of elderly Japanese patients with non-small cell lung cancer: subanalysis of a real-world retrospective observational study (CA209-9CR). Esmo Open. 2020 Jul;5(4):10.(沖塩協一)
 
  1. T. Yanagihara, Y. Inoue. Insights into pathogenesis and clinical implications in myositis-associated interstitial lung diseases. Curr Opin Pulm Med. 26(5):507ー517.(井上義一)
 
  1. H. Hatabu, G. M. Hunninghake, L. Richeldi, K. K. Brown, A. U. Wells, M. Remy-Jardin, J. Verschakelen, A. G. Nicholson, M. B. Beasley, D. C. Christiani, R. San José Estépar, J. B. Seo, T. Johkoh, N. Sverzellati, C. J. Ryerson, R. Graham Barr, J. M. Goo, J. H. M. Austin, C. A. Powell, K. S. Lee, Y. Inoue, D. A. Lynch. Interstitial lung abnormalities detected incidentally on CT: a Position Paper from the Fleischner Society. Lancet Respiratory Medicine. 2020 Jul;8(7):726ー737.(井上義一)
 
  1. A. Tamiya, S. I. Isa, Y. Taniguchi, H. Nakagawa, S. Atagi, M. Ando, Y. Koh. Prospective Observational Study of Treatment Resistance-related Gene Screening Using Plasma Circulating Tumor DNA in Third-generation EGFR-TKI Osimertinib Therapy (Elucidator). Clin Lung Cancer. (田宮朗裕)
 
  1. T. Arai, T. Kasai, K. Shimizu, K. Kawahara, K. Katayama, C. Sugimoto, M. Hirose, H. Okamoto, K. Tachibana, M. Akira, Y. Inoue. Autoimmune Pulmonary Alveolar Proteinosis Complicated with Sarcoidosis: the Clinical Course and Serum Levels of Anti-granulocyte-macrophage colony-stimulating Factor Autoantibodv. Internal Medicine. 2020;59(20):2539ー2546.(新井徹)
 
  1. Yoshinobu Matsuda, Ryo Matsunuma, Kozue Suzuki, Masanori Mori, Hiroaki Watanabe, and Takashi Yamaguchi. Physician-Perceived Predictive Factors for the Effectiveness of Drugs for Treating Cancer Dyspnea: Results of a Nationwide Survey of Japanese Palliative Care Physicians. Palliat Med Reports. 2020 Jul;1(1):(松田能宣)
 
  1. Y. Adachi, K. Tsuyuguchi, T. Kobayashi, Y. Kurahara, S. Yoshida, T. Kagawa, S. Hayashi, K. Suzuki. Effective treatment for clarithromycin-resistant Mycobacterium avium complex lung disease. Journal of Infection and Chemotherapy. 2020 Jul;26(7):676ー680.(足立雄一)
 
  1. S. Minomo, T. Arai, H. Higo, T. Tsuji, K. Tachibana, M. Akira, Y. Inoue. Characteristics and prognosis of interstitial pneumonias complicated with pneumomediastinum. Respiratory Investigation. 2020 Jul;58(4):262ー268.(蓑毛祥次郎)
 
  1. G. D. Rubin, C. J. Ryerson, L. B. Haramati, N. Sverzellati, J. P. Kanne, S. Raoof, N. W. Schluger, A. Volpi, J. J. Yim, I. B. K. Martin, D. J. Anderson, C. Kong, T. Altes, A. Bush, S. R. Desai, J. Goldin, J. M. Goo, M. Humbert, Y. Inoue, H. U. Kauczor, F. Luo, P. J. Mazzone, M. Prokop, M. Remy-Jardin, L. Richeldi, C. M. Schaefer-Prokop, N. Tomiyama, A. U. Wells, A. N. Leung. The Role of Chest Imaging in Patient Management During the COVID-19 Pandemic: A Multinational Consensus Statement From the Fleischner Society. Chest. 2020 Jul;158(1):106ー116.(井上義一)
 
  1. R. Matsunuma, K. Suzuki, Y. Matsuda, M. Mori, H. Watanabe, T. Yamaguchi. Palliative care physicians' perspectives of management for terminally ill cancer patients with death rattle: a nationwide survey. Japanese Journal of Clinical Oncology. 2020 Jul;50(7):830ー833.(松田能宣)
 
  1. H. Kobayashi, T. Takimoto, H. Kitaoka, T. Kijima. Aerosol spread with use of high-flow nasal cannulae: a computational fluid dynamics analysis. J Hosp Infect. 106(1):204ー205.(小林岳彦)
 
  1. T. Takimoto, S. Minomo, K. Azuma, K. Tsuyuguchi, K. Suzuki. A rare cause of pneumatosis intestinalis: Intestinal amyloidosis reactive to pulmonary Mycobacterium avium infection. Int J Infect Dis. 97329ー330.(滝本宜之)
 
  1. N. Eura, T. K. Matsui, J. Luginbühl, M. Matsubayashi, H. Nanaura, T. Shiota, K. Kinugawa, N. Iguchi, T. Kiriyama, C. Zheng, T. Kouno, Y. J. Lan, P. Kongpracha, P. Wiriyasermkul, Y. M. Sakaguchi, R. Nagata, T. Komeda, N. Morikawa, F. Kitayoshi, M. Jong, S. Kobashigawa, M. Nakanishi, M. Hasegawa, Y. Saito, T. Shiromizu, Y. Nishimura, T. Kasai, M. Takeda, H. Kobayashi, Y. Inagaki, Y. Tanaka, M. Makinodan, T. Kishimoto, H. Kuniyasu, S. Nagamori, A. R. Muotri, J. W. Shin, K. Sugie, E. Mori. Brainstem Organoids From Human Pluripotent Stem Cells. Frontiers in Neuroscience. 2020 Jun;1414.(武田麻衣子)
 
  1. A. U. Wells, K. R. Flaherty, K. K. Brown, Y. Inoue, A. Devaraj, L. Richeldi, T. Moua, B. Crestani, W. A. Wuyts, S. Stowasser, M. Quaresma, R. G. Goeldner, R. Schlenker-Herceg, M. Kolb. Nintedanib in patients with progressive fibrosing interstitial lung diseases-subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised, double-blind, placebo-controlled, parallel-group trial. Lancet Respiratory Medicine. 2020 May;8(5):453ー460.(井上義一)
 
  1. I. Okamoto, H. Nokihara, S. Nomura, S. Niho, S. Sugawara, H. Horinouchi, K. Azuma, Y. Yoneshima, H. Murakami, Y. Hosomi, S. Atagi, T. Ozaki, A. Horiike, Y. Fujita, H. Okamoto, M. Ando, N. Yamamoto, Y. Ohe, K. Nakagawa. Comparison of Carboplatin Plus Pemetrexed Followed by Maintenance Pemetrexed With Docetaxel Monotherapy in Elderly Patients With Advanced Nonsquamous Non-Small Cell Lung Cancer A Phase 3 Randomized Clinical Trial. Jama Oncology. 2020 May;6(5):9.(安宅信二)
 
  1. Y. Matsuda, H. Tanimukai, S. Inoue, S. Inada, K. Sugano, H. Hasuo, M. Yoshimura, S. Wada, C. Dotani, H. Adachi, Y. Okamoto, M. Takeuchi, D. Fujisawa, J. Kako, C. Sasaki, Y. Kishi, N. Akizuki, M. Inagaki, Y. Uchitomi, E. Matsushima, T. Okuyama. JPOS/JASCC clinical guidelines for delirium in adult cancer patients: a summary of recommendation statements. Japanese Journal of Clinical Oncology. 2020 May;50(5):586ー593.(松田能宣)
 
  1. Y. Inoue, R. J. Kaner, J. Guiot, T. M. Maher, S. Tomassetti, S. Moiseev, M. Kuwana, K. K. Brown. Diagnostic and Prognostic Biomarkers for Chronic Fibrosing Interstitial Lung Diseases With a Progressive Phenotype. Chest. 158(2):646ー659.(井上義一)
 
  1. A. Tamiya, Y. Koh, S. I. Isa, A. Kubo, M. Ando, H. Saka, N. Yoshimoto, S. Takeo, H. Adachi, T. Tagawa, O. Kawashima, M. Yamashita, K. Kataoka, M. Takenoyama, Y. Takeuchi, K. Watanabe, A. Matsumura, T. Kawaguchi. Impact of somatic mutations on prognosis in resected non-small-cell lung cancer: The Japan Molecular Epidemiology for lung cancer study. Cancer Medicine. 2020 Apr;9(7):2343ー2351.(田宮朗裕)
 
  1. Y. Inagaki, K. Tachibana, Y. Inoue, T. Kasai, Y. Inoue. Severe clopidogrel-induced DRESS with eosinophilic pneumonia associated with Epstein-Barr virus reactivation. Respirology Case Reports. 2020 Apr;8(3):4.(稲垣雄士)
 
  1. Y. Minegishi, A. Gemma, S. Homma, K. Kishi, A. Azuma, T. Ogura, N. Hamada, H. Taniguchi, N. Hattori, Y. Nishioka, K. Tanizawa, T. Johkoh, T. Yokoyama, K. Mori, Y. Taguchi, M. Ebina, N. Inase, K. Hagiwara, H. Ohnishi, H. Mukae, Y. Inoue, K. Kuwano, H. Chiba, K. Ohta, Y. Tanino, F. Sakai, Y. Sugiyama. Acute exacerbation of idiopathic interstitial pneumonias related to chemotherapy for lung cancer: nationwide surveillance in Japan. Erj Open Research. 2020 Apr;6(2):9.(井上義一)
 
  1. T. Arai, H. Kida, Y. Ogata, S. Marumo, H. Matsuoka, I. Gohma, S. Yamamoto, M. Mori, C. Sugimoto, K. Tachibana, M. Akira, Y. Inoue. Efficacy of recombinant thrombomodulin for poor prognostic cases of acute exacerbation in idiopathic interstitial pneumonia: Secondary analysis of the SETUP trial. BMJ Open Respiratory Research. 2020 Mar;7(1):11.(新井徹)
 
  1. R. Morita, K. Okishio, J. Shimizu, H. Saito, H. Sakai, Y. H. Kim, O. Hataji, M. Yomota, M. Nishio, K. Aoe, O. Kanai, T. Kumagai, K. Kibata, H. Tsukamoto, S. Oizumi, D. Fujimoto, H. Tanaka, K. Mizuno, T. Masuda, T. Kozuki, T. Haku, H. Suzuki, I. Okamoto, H. Hoshiyama, J. Ueda, Y. Ohe. Real-world effectiveness and safety of nivolumab in patients with non-small cell lung cancer: A multicenter retrospective observational study in Japan. Lung Cancer. 2020 Feb;1408ー18.(沖塩協一)
 
  1. Y. Kondoh, A. Azuma, Y. Inoue, T. Ogura, S. Sakamoto, K. Tsushima, T. Johkoh, K. Fujimoto, K. Ichikado, Y. Matsuzawa, T. Saito, K. Kishi, K. Tomii, N. Sakamoto, M. Aoshima, J. Araya, S. Izumi, M. Arita, M. Abe, H. Yamauchi, J. Shindoh, T. Suda, M. Okamoto, M. Ebina, Y. Yamada, Y. Tohda, T. Kawamura, Y. Taguchi, H. Ishii, N. Hashimoto, S. Abe, H. Taniguchi, J. Tagawa, K. Bessho, N. Yamamori, S. Homma. Thrombomodulin alfa for Acute Exacerbation of Idiopathic Pulmonary Fibrosis: A Randomized, Double-blind, Placebo-controlled Trial. Am J Respir Crit Care Med. 201(9):1110ー1119.(井上義一)
 
  1. T. Kobayashi, K. Tsuyuguchi, S. Yoshida, Y. Kurahara, S. Minomo, Y. Inoue, K. Suzuki. Serum immunoglobulin a antibodies to glycopeptidolipid core antigen for Mycobacteroides abscessus complex lung disease. International Journal of Mycobacteriology. 2020 Jan-Mar;9(1):76ー82.(小林岳彦)
 
  1. K. Nakata, T. Sugi, K. Kuroda, K. Yoshizawa, T. Takada, R. Tazawa, T. Ueda, A. Aoki, M. Abe, K. Tatsumi, R. Eda, S. Kondoh, K. Morimoto, T. Tanaka, E. Yamaguchi, A. Takahashi, M. Oda, H. Ishii, S. Izumi, H. Sugiyama, A. Nakagawa, K. Tomii, M. Suzuki, S. Konno, S. Ohkouchi, T. Hirano, T. Handa, T. Hirai, Y. Inoue, T. Arai, K. Asakawa, T. Sakagami, T. Tanaka, A. Mikami, N. Kitamura. Validation of a new serum granulocyte-macrophage colony-stimulating factor autoantibody testing kit. Erj Open Research. 2020 Jan;6(1):10.(井上義一)
 
  1. M. Tamiya, A. Tamiya, H. Suzuki, Y. Taniguchi, K. Katayama, S. Minomo, K. Nakao, N. Takeuchi, Y. Matsuda, Y. Naito, T. Shiroyama, N. Okamoto, K. Okishio, T. Kumagai, S. Atagi, F. Imamura, T. Hirashima. Phase 2 study of bevacizumab plus carboplatin/nab-paclitaxel followed by bevacizumab plus nab-paclitaxel for non-squamous non-small cell lung cancer with malignant pleural effusion. Investigational New Drugs. 7.(田宮朗裕)
 
 
和文原著・著書等
1. 井上義一. 進行性線維化を伴う間質性肺疾患（PF-ILD）の概念とその管理. 呼吸器内科. 2021;39(3):171-177.
2. 増井伸高、倉原優ら. CASE7 呼吸器内科医にコンサルト. 救急現場から専門医へ あの先生にコンサルトしよう!. 2021;
3. 倉原優. 空間除菌は無意味どころか・・・. 日本医事新報. 2021;(5054):60.
4. 倉原優. 呼吸器感染症よもやま話.(25) . J-IDEO. 2021;5(2):260-261.
5. 倉原優. 新型コロナウイルス（SARS-CoV-2）ワクチンの副反応報道が始まった. 日本医事新報. 2021;(5050):70.
6. 松田能宣.  緩和治療薬. 呼吸器薬物療法-現場ではこう使いこなす. 呼吸器ジャーナル. 2021;69(1):p126-131.
7. 澄川裕充, 井上義一. 間質性肺炎の画像特徴. リウマチ科. 2021;65(1):44519.
8. 倉原優. SARS-CoV-2核酸ワクチンの期待と懸念. 日本医事新報. 2021;(5047):56-57.
9. 倉原優. 呼吸器感染症よもやま話.(24). J-IDEO. 2021;5(1):82-83.
10. 一和多俊男，内田寛治，石田学，赤坂　圭一，新井　　徹，大河内眞也，富井　啓介，山口　悦郎，井上　義一，中田　　光. 自己免疫性肺胞蛋白症に対する片側全肺洗浄法に関するワークショップサマリー. 日本呼吸器学会誌. 2021;10(1):44236.
11. 井上義一. 進行性線維化を伴う間質性肺疾患(PF-ILD)/進行性フェノタイプを示す慢性線維化性間質性肺疾患：新たな概念. 呼吸器内科. 2020;38(6):576-581.
12. 松田能宣.  かかりつけ医に必要な心療内科の知識 呼吸器・アレルギー心身症：喘息患者で使える心身医学的アプローチ. 日臨内科医会誌. 2020;35(4):p317-320.
13. 倉原優. 大阪府のコロナ第3波の現状. 日本医事新報. 2020;(5041):56.
14. 松田能宣. 心療内科医が実践する緩和ケア. Gノート. 2020;7(8):p1326-1331.
15. 松田能宣. 超実践的!だれでも使える心理療法のエッセンス(第4回)　交流分析を意識したコミュニケーション. 薬事. 2020;62(16):p1326-1331.
16. 井上義一. リンパ脈管筋腫症. 最新ガイドラインに基づく 呼吸器疾患 診療指針 2021-'22. 2020;415-421.
17. 倉原優. 肺結核の診断エラーはなぜ起こる？. 医学と薬学. 2020;77(4):473-476.
18. 倉原優. プレプリントの功罪. 日本医事新報. 2020;(5038):56.
19. 倉原優. インフルは咳から、COVID-19は熱から. 日経メディカル. 2020;1152-53.
20. 倉原優. 呼吸器感染症よもやま話.(23) . J-IDEO. 2020;4(6):954-956.
21. 吉田志緒美. 特集・非結核性抗酸菌症を考える：肺疾患を中心に　非結核性抗酸菌の主要薬剤の耐性機序. 呼吸器内科. 2020;38(5):464～474.
22. 松田能宣.  FAST FACT パニック発作・パニック症. 緩和ケア. 2020;30(6):p491.
23. 上西珠実、今長京子、土田麗央奈、佐々木達彦、玉舎学、吉田志緒美、樋口富士夫. 呼気一酸化窒素（FENO）測定の季節性変動について. 医学検査. 2020;69(4):534～538.
24. 松田能宣.  第2章. 3. 慢性閉塞性肺疾患（COPD）. 月刊薬事. 2020;62(14):p60-66.
25. 倉原優. 咳・痰.  総合診療. 2020;30(10):1191-1194.
26. 倉原優. SNSで広がるHPVワクチンのクラウドファンディング. 日本医事新報. 2020;(5033):64-65.
27. 井上義一. 治療最前線 抗線維化剤｢オフェブ｣. 薬事ニュース. 2020;14.
28. 久村正樹、倉原優ら. 気管支鏡. ERで闘うための手技. 2020;246-255.
29. 鈴木克洋. 特集「肺炎」肺結核と肺非結核性抗酸菌症. Medical Practice. 2020;37(10):1537-1540.
30. 井上義一, 西山理, 尾形誠. ご存知ですか？徳栄製肺線維症（ＩＰＦ）. 産経新聞 朝刊. 2020;20.
31. 松田能宣. 第3章. 5 非がんの呼吸器疾患で使える薬剤のバリエーションは？. 倉田宝保監修 蓮尾英明編集 がん治療医が本当に知りたかった緩和ケアのレシピ. 2020;p271-272.
32. 倉原優. 増えるマスク熱中症. 日本医事新報. 2020;(5029):61.
33. 倉原優. 呼吸器感染症よもやま話.(22). J-IDEO. 2020;4(5):794-795.
34. 松田能宣.  超実践的!だれでも使える心理療法のエッセンス(第1回)　リフレーミング. 月刊薬事. 2020;62(12):p2393-2396.
35. 松田能宣. 実践施設に学ぶ！患者の「生きる」を支えるPCT当院の緩和ケアチーム活動の実践報告【第26回】呼吸器疾患専門病院としての緩和ケアチーム活動. エンド・オブ・ライフケア. 2020;4(4):p95-98.
36. 松田能宣.  肺がん患者の緩和ケアとアドバンス・ケア・プランニング. 日本呼吸ケア・リハビリテーション学会誌. 2020; 29巻(1号): Page75-77.
37. 倉原優. コロナ禍の最前線に立つ看護師の大量辞職. 日本医事新報. 2020;(5025):57.
38. 松田能宣 . 第2章 3) 不安と呼吸困難・不定愁訴. 小山敦子編集 がん診療における精神症状心理状態発達障害ハンドブック. 2020;p99-106.
39. 松田能宣. 総論. V治療. 24. 呼吸器疾患の緩和ケア. B. 非悪性腫瘍. 新 呼吸器専門医テキスト改訂第2版. 2020;p311-312.
40. 倉原優. 過剰な感染対策. 日本医事新報. 2020;(5020):59.
41. 倉原優. COVID-19（新型コロナウイルス感染症）のまん延期. コミュニティケア. 2020;22(8):25-28.
42. 倉原優. 呼吸器感染症よもやま話.(21). J-IDEO. 2020;4(4):668-669.
43. 倉原優. 書評「非がん患者の緩和ケア」. 薬事. 2020;62(9):74.
44. 吉田志緒美.  技術講座 微生物;抗酸菌検査 . 検査と技術. 2020;48(7):700～708.
45. 小山敦子, 所昭宏2 山田祐. 心身医学とサイコオンコロジーの未来戦略 ~心療内科医の立場から~ . 日本心療内科学会誌. 2020;24(2):５５－６２.
46. 佐々木由美子, 井上義一. 4　慢性好酸球性肺炎(CEP). 間質性肺疾患診療マニュアル（改訂第3版）. 2020;462-464.
47. 倉原優. 医療者へのCOVID-19差別. 日本医事新報. 2020;(5016):55.
48. 片山加奈子, 新井徹, 笠井孝彦, 審良正則, 井上義一. AL アミロイドーシス -自験例と文献的考察-. BIO Clinica. 2020;35(6):73-78.
49. 倉原優. 呼吸器内科領域の勘違いプラクティス. J-COSMO. 2020;2(3):420-421.
50. 川瀬啓祐、吉田志緒美、中郡翔太郎、古林与志安、椎原春一. 3種類の非結核性抗酸菌による肉芽腫病変が認められたボールニシキヘビ（Python regius）の全身播種性感染症の一例 . 日本野生動物医学会誌. 2020;25(1):35～40.
51. 倉原優. それほど専門家ではない専門家がテレビに出ている件. 日本医事新報. 2020;(5012):67.
52. 倉原優. 肺癌の分子標的薬の誕生. 総合診療. 2020;30(5):549-552.
53. 松本錦之介、小林岳彦、倉原優、嶋谷泰明、木原実香、吉田志緒美、露口一成、鈴木克洋、林清二. Mycobacterium kansasiiと結核菌の混合感染として治療を行なった後に多剤耐性結核を発症した１例 . 結核 . 2020;95(3):99～102.
54. 倉原優. なぜかHPVワクチンが接種されない先進国. 日本医事新報. 2020;(5010):63.
55. 倉原優. 呼吸器感染症よもやま話.(20). J-IDEO. 2020;4(3):394-395.
56. 岡田全司. 結核ワクチンの現状と展望（結核治療・予防ワクチンの治験を含む）. 呼吸器内科. 2020;37(5):512-519.
57. 井上義一. 抗線維化薬. 膠原病に伴う間質性肺疾患 診断・治療指針2020. 2020;190-195.
58. 井上義一. 進行性フェノタイプを示す慢性線維化性間質性肺疾患（進行性線維化を伴う間質性肺疾患）. 膠原病に伴う間質性肺疾患 診断・治療指針2020. 2020;146-150.
59. 井上義一. 進行性フェノタイプを示す慢性線維化性間質性肺疾患（進行性線維化を伴う間質性肺疾患）. 膠原病に伴う間質性肺疾患 診断・治療指針2020. 2020;190-195.
60. 倉原優. COVID-19による外勤禁止が招く医療崩壊. 日本医事新報. 2020;(5008):63.
61. 倉原優. Twitterで叫ばれる医師過労問題、つまるところお金の問題. 日本医事新報. 2020;(5006):64.
62. 倉原優. ポケット呼吸器診療2020. ポケット呼吸器診療2020. 2020;
63. 倉原優. 呼吸器内科のダメ処方. J-COSMO. 2020;2(2):209.
64. 倉原優. 新型コロナウイルス感染症を知るための11の論文. J-IDEO＋. 2020;442-57.
65. 倉原優. 早分かり診療ガイドライン. 慢性閉塞性肺疾患（COPD）. medicina. 2020;57(4):87-89.
 
ページトップへ